Vistin Pharma ASA (OSTO:VISTINO) Interest Expense : kr11.3 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Vistin Pharma ASA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vistin Pharma ASA's interest expense for the three months ended in Sep. 2024 was kr -4.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was kr11.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vistin Pharma ASA's Operating Income for the three months ended in Sep. 2024 was kr 24.1 Mil. Vistin Pharma ASA's Interest Expense for the three months ended in Sep. 2024 was kr -4.3 Mil. Vistin Pharma ASA's Interest Coverage for the quarter that ended in Sep. 2024 was 5.59. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vistin Pharma ASA Interest Expense Historical Data

The historical data trend for Vistin Pharma ASA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vistin Pharma ASA Interest Expense Chart

Vistin Pharma ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.22

-0.82

-0.36

-2.14

-2.27

Vistin Pharma ASA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-0.80	23.84	-7.59	-0.63	-4.31

Vistin Pharma ASA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr11.3 Mil.

Vistin Pharma ASA (OSTO:VISTINo) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vistin Pharma ASA's Interest Expense for the three months ended in Sep. 2024 was kr-4.3 Mil. Its Operating Income for the three months ended in Sep. 2024 was kr24.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was kr1.5 Mil.

Vistin Pharma ASA's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2024 )	/	Interest Expense (Q: Sep. 2024 )
	=	-1	*	24.063	/	-4.306
	=	5.59

The higher the ratio, the stronger the company's financial strength is.

Vistin Pharma ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vistin Pharma ASA (OSTO:VISTINo) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

VISTN:Norway 0RAM:UK VP4:Germany

Address

Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661

Website

https://www.vistin.com

Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.

Vistin Pharma ASA Headlines

No Headlines